TSRI researchers uncover potential target for treating autoimmune disease

February 22, 2016

LA JOLLA, CA - February 22, 2016 - Scientists from The Scripps Research Institute (TSRI) have identified a molecule that appears to be a cause of autoimmune diseases such as lupus. Elevated levels of the molecule allow self-reactive immune cells to escape into the blood stream and attack the body's own tissues.

"This is a good target for future therapies," said TSRI Associate Professor Changchun Xiao, who was co-senior author of the study with TSRI Professor David Nemazee. "We now know that this is causative--it's not just a side effect."

The research, published February 22, 2016, in the journal Nature Immunology, focused on the identification of a specific microRNA (miRNA)--a small non-coding RNA molecule playing a role in regulating gene expression--that affects the immune system.

Alicia Gonzalez-Martin, research associate in the Xiao lab and first author of the new study, was excited by the discovery. "This is the first miRNA implicated in the regulation of B cell tolerance," she said.

Clues in Mouse Models

Immune cells known as B cells develop in the bone marrow and acquire specific receptors in a random assembly process that helps the body prepare to fight different enemies, including a multitude of viruses and bacteria. Xiao compared the assembly process to handing soldiers different kinds of weapons--a rifle for one soldier, a bayonet for another.

Normally, the body also has a system of B cell tolerance checkpoints in place to eliminate self-reactive B cells, which attack not only germs but also the body's own tissues. This process, which relies on apoptosis (programmed cell death), seems to go awry in patients with autoimmune diseases. "For some reason, their self-reactive B cells have not been purged," said Xiao.

The new research began when Nemazee's lab engineered a mouse model of immune tolerance, which rendered all B cells self-reactive. As a result, the cells continually eliminated themselves by natural self-tolerance processes, leading to an absence of B cells in the body. The researchers, however, noticed a strange phenomenon--as the mice got older, some self-reactive B cells escaped into the blood stream. The phenomenon reminded the researchers of cells seen in autoimmune diseases and suggested a way to search for genes whose dysregulation hindered tolerance and promoted such diseases.

The scientists hypothesized that some of the more than 1,000 known miRNAs might be affecting the gene expression regulating the survival or destruction of self-reactive B cells. The challenge was to pinpoint the exact miRNA responsible.

"This was a risky project because we weren't sure if any miRNA at all would regulate B cell tolerance," explained Gonzalez-Martin.

Setting the Trap

Finding the miRNA culprit meant setting a trap.

The team first generated its own self-reactive B cells by prompting a virus to express select miRNAs in haematopoietic stem cells (stem cells producing blood cells and platelets). The researchers then seeded the bone marrow of the Nemazee lab's mouse model with these cells.

Eventually, some of these self-reactive B cells escaped into the spleens of the mice, where researchers caught and analyzed the miRNAs expressed.

The researchers found elevated expression of a specific miRNA called miR-148a that was responsible for B cell escape. MiR-148a suppressed three genes that control apoptosis. Without apoptosis, self-reactive mutants were not purged.

When the team prompted mouse models of lupus to overexpress miR-148a, the mice developed lupus faster than their counterparts with normal miR-148a expression. Interestingly, miR-148a is also overexpressed in many human lupus patients.

"This brings us to a pathway that we might be able to regulate with a therapeutic," Nemazee said.

The researchers said the next step is to investigate miR-148a's other functions in the body to see if inhibiting its actions would have any negative side effects.
-end-
In addition to Xiao, Nemazee and Gonzalez-Martin, authors of the study "The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity," were Brian D. Adams and Jun Lu of Yale University; Maria Salvador-Bernaldez and Jesus M. Salvador of the National Biotechnology Center, Madrid, Spain; and Maoyi Lai and Jovan Shepherd of TSRI.

The study was supported by the Pew Charitable Trusts, The Cancer Research Institute, Lupus Research Institute and National Institutes of Health (grants R01 AI089854, R01 AI59714 and RC4 AI092763).

Scripps Research Institute

Related Bone Marrow Articles from Brightsurf:

Researchers identify the mechanism behind bone marrow failure in Fanconi anaemia
Researchers at the University of Helsinki and the Dana-Farber Cancer Institute have identified the mechanism behind bone marrow failure developing in children that suffer from Fanconi anaemia.

Nanoparticles can turn off genes in bone marrow cells
Using specialized nanoparticles, MIT engineers have developed a way to turn off specific genes in cells of the bone marrow, which play an important role in producing blood cells.

How stress affects bone marrow
Researchers from Tokyo Medical and Dental University (TMDU) identified the protein CD86 as a novel marker of infection- and inflammation-induced hematopoietic responses.

3D atlas of the bone marrow -- in single cell resolution
Stem cells located in the bone marrow generate and control the production of blood and immune cells.

Dangerous bone marrow, organ transplant complication explained
Scientists have discovered the molecular mechanism behind how the common cytomegalovirus can wreak havoc on bone marrow and organ transplant patients, according to a paper published in the journal Cell & Host Microbe.

Viagra shows promise for use in bone marrow transplants
Researchers at UC Santa Cruz have demonstrated a new, rapid method to obtain donor stem cells for bone marrow transplants using a combination of Viagra and a second drug called Plerixafor.

Bone marrow may be the missing piece of the fertility puzzle
A woman's bone marrow may determine her ability to start and sustain a pregnancy, report Yale researchers in PLOS Biology.

Cells that make bone marrow also travel to the womb to help pregnancy
Bone marrow-derived cells play a role in changes to the mouse uterus before and during pregnancy, enabling implantation of the embryo and reducing pregnancy loss, according to research published Sept.

Uncovering secrets of bone marrow cells and how they differentiate
Researchers mapped distinct bone marrow niche populations and their differentiation paths for the bone marrow factory that starts from mesenchymal stromal cells and ends with three types of cells -- fat cells, bone-making cells and cartilage-making cells.

Zebrafish help researchers explore alternatives to bone marrow donation
UC San Diego researchers discover new role for epidermal growth factor receptor in blood stem cell development, a crucial key to being able to generate them in the laboratory, and circumvent the need for bone marrow donation.

Read More: Bone Marrow News and Bone Marrow Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.